Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Asian Journal of Urology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388222000509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850260482628255744 |
|---|---|
| author | Masayuki Kurokawa Sei Naito Tomoyuki Kato Masaki Ushijima Atsushi Yamagishi Toshihiko Sakurai Hayato Nishida Norihiko Tsuchiya |
| author_facet | Masayuki Kurokawa Sei Naito Tomoyuki Kato Masaki Ushijima Atsushi Yamagishi Toshihiko Sakurai Hayato Nishida Norihiko Tsuchiya |
| author_sort | Masayuki Kurokawa |
| collection | DOAJ |
| format | Article |
| id | doaj-art-84e0028163cc42ac801cf8bbd33986e1 |
| institution | OA Journals |
| issn | 2214-3882 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Urology |
| spelling | doaj-art-84e0028163cc42ac801cf8bbd33986e12025-08-20T01:55:38ZengElsevierAsian Journal of Urology2214-38822023-01-0110110310510.1016/j.ajur.2022.01.005Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinomaMasayuki Kurokawa0Sei Naito1Tomoyuki Kato2Masaki Ushijima3Atsushi Yamagishi4Toshihiko Sakurai5Hayato Nishida6Norihiko Tsuchiya7Corresponding author.; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, JapanDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, Japanhttp://www.sciencedirect.com/science/article/pii/S2214388222000509 |
| spellingShingle | Masayuki Kurokawa Sei Naito Tomoyuki Kato Masaki Ushijima Atsushi Yamagishi Toshihiko Sakurai Hayato Nishida Norihiko Tsuchiya Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma Asian Journal of Urology |
| title | Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| title_full | Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| title_fullStr | Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| title_full_unstemmed | Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| title_short | Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| title_sort | complete response to an anti programmed cell death 1 antibody following a combination therapy of an anti programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma |
| url | http://www.sciencedirect.com/science/article/pii/S2214388222000509 |
| work_keys_str_mv | AT masayukikurokawa completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT seinaito completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT tomoyukikato completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT masakiushijima completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT atsushiyamagishi completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT toshihikosakurai completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT hayatonishida completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma AT norihikotsuchiya completeresponsetoanantiprogrammedcelldeath1antibodyfollowingacombinationtherapyofanantiprogrammedcelldeathligand1antibodyandatyrosinekinaseinhibitorformetastaticrenalcellcarcinoma |